Patent ID: 8440893
Filing Date: 2013-05-14
Classification: A61K,A61P

Abstract:
1. A method for treating arthritis or bone destruction associated with arthritis in a patient, comprising the step of administering to the patient at least one selected from the group consisting of an un-substituted fullerene, a clathrate fullerene, and a fullerene derivative, wherein the fullerene derivative is selected from the group consisting of heterofullerene, norfullerene, homofullerene, secofullerene, a fullerene polymer, a fullerene substituted with a hydroxyl group, an amino group, or a carboxyl group and salts thereof, wherein a dosage is 0.1 μM to 100 μM per affected part, thereby treating the arthritis or bone destruction associated with arthritis in the patient.